Research graph
References from Racial and Ethnic Disparities in Treatment Discontinuation in Pregnant Females With Opioid Use Disorder. Local targets link to admitted publications; unresolved targets remain external evidence.
Opioid use disorder documented at delivery hospitalization—United States, 1999-2014.
10.15585/mmwr.mm6731a1 · 2018 · External reference
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
10.1136/bmj.j1550 · 2017 · External reference
Racial inequality in receipt of medications for opioid use disorder.
10.1056/nejmsa2212412 · 2023 · External reference
Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations.
10.1371/journal.pone.0067405 · 2013 · External reference
Development and validation of algorithms to estimate live birth gestational age in Medicaid Analytic eXtract data.
10.1097/ede.0000000000001559 · 2023 · External reference
Medication adherence: a call for action.
10.1016/j.ahj.2011.06.007 · 2011 · External reference
Buprenorphine and methadone discontinuation during pregnancy and the postpartum period: a nationwide cohort study.
10.1176/appi.ajp.20241127 · 2025 · External reference
Racial and ethnic inequities in buprenorphine and methadone utilization among reproductive-age women with opioid use disorder: an analysis of multi-state Medicaid claims in the USA.
10.1007/s11606-023-08306-0 · 2023 · External reference
Receipt of buprenorphine and naltrexone for opioid use disorder by race and ethnicity and insurance type.
10.1001/jamanetworkopen.2025.18493 · 2025 · External reference
